<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations/><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/3A5E126D-C175-4730-9B7B-E6D8CF447F83"><gtr:id>3A5E126D-C175-4730-9B7B-E6D8CF447F83</gtr:id><gtr:name>University College London</gtr:name><gtr:department>Biochemical Engineering</gtr:department><gtr:address><gtr:line1>Gower Street</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>WC1E 6BT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/3A5E126D-C175-4730-9B7B-E6D8CF447F83"><gtr:id>3A5E126D-C175-4730-9B7B-E6D8CF447F83</gtr:id><gtr:name>University College London</gtr:name><gtr:address><gtr:line1>Gower Street</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>WC1E 6BT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/C80ECD4B-F122-46D8-9693-E8D7E50DE432"><gtr:id>C80ECD4B-F122-46D8-9693-E8D7E50DE432</gtr:id><gtr:name>ISIS Facility</gtr:name><gtr:address><gtr:line1>Rutherford Appleton Laboratory</gtr:line1><gtr:line4>Chilton, Didcot</gtr:line4><gtr:line5>Oxon</gtr:line5><gtr:postCode>OX11 0QX</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>PROJECT_PARTNER</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/CE202CD1-E56B-4594-85E0-A78B5059975C"><gtr:id>CE202CD1-E56B-4594-85E0-A78B5059975C</gtr:id><gtr:name>University of Delaware</gtr:name><gtr:address><gtr:line1>University of Delaware</gtr:line1><gtr:line4>Newark</gtr:line4><gtr:line5>Delaware DE 19716</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>PROJECT_PARTNER</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/7379B9E6-A706-44B9-B453-B1E18577E136"><gtr:id>7379B9E6-A706-44B9-B453-B1E18577E136</gtr:id><gtr:name>NIST (Nat. Inst of Standards and Technol</gtr:name><gtr:address><gtr:line1>100 Bureau Drive</gtr:line1><gtr:line4>Gaithersburgh</gtr:line4><gtr:postCode>MD 20899-8</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>PROJECT_PARTNER</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/2E0BBB9D-2AE8-4368-A89A-665317171804"><gtr:id>2E0BBB9D-2AE8-4368-A89A-665317171804</gtr:id><gtr:firstName>Paul</gtr:firstName><gtr:otherNames>Anthony</gtr:otherNames><gtr:surname>Dalby</gtr:surname><gtr:orcidId>0000-0002-0980-8167</gtr:orcidId><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/A8ACADD2-6AB0-4C00-BE1E-C69D90DBBE5A"><gtr:id>A8ACADD2-6AB0-4C00-BE1E-C69D90DBBE5A</gtr:id><gtr:firstName>Daniel</gtr:firstName><gtr:otherNames>Gilbert</gtr:otherNames><gtr:surname>Bracewell</gtr:surname><gtr:orcidId>0000-0003-3866-3304</gtr:orcidId><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=BB%2FK021354%2F1"><gtr:id>E5A3401B-7A02-4B2B-806F-E6D0AC3C4725</gtr:id><gtr:title>US partnering on the use of neutron scattering to study aggregation in therapeutic proteins during manufacture and storage</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>BB/K021354/1</gtr:grantReference><gtr:abstractText>Abstracts are not currently available in GtR for all funded research. This is normally because the abstract was not required at the time of proposal submission, but may be because it included sensitive information such as personal details.</gtr:abstractText><gtr:fund><gtr:end>2016-12-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/2512EF1C-401B-4222-9869-A770D4C5FAC7"><gtr:id>2512EF1C-401B-4222-9869-A770D4C5FAC7</gtr:id><gtr:name>BBSRC</gtr:name></gtr:funder><gtr:start>2013-05-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>43192</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs/><gtr:disseminationOutputs/><gtr:exploitationOutputs/><gtr:furtherFundingOutputs/><gtr:impactSummaryOutputs><gtr:impactSummaryOutput><gtr:description>This work has opened up a dialogue with NIST scientists working also on biopharmaceutical measurements. NIST have now promised to supply materials for a new EPSRC grant application in the UK. The work has also led to a collaborative EPSRC CDT PhD with UCL (Dalby), Chris Roberts in Delaware, and Univ Manchester (Curtis). The work at ISIS has also enabled a jointly funded UCL EPSRC CDT PhD project to launch in Oct 2016, to investigate glycosylation structures in antibodies in solution.

Two conferences have also been organised as a result of this collaborative project.

1. Neutron Characterisation in Fundamental and Applied Biotechnology, Abingdon, UK, September 2014

2. Advances in Biophysical Methods for Protein Characterisation, Palermo, Italy, October 2016.</gtr:description><gtr:firstYearOfImpact>2016</gtr:firstYearOfImpact><gtr:id>9B62F3E2-1523-4B66-AC10-05A6680DECF7</gtr:id><gtr:impactTypes><gtr:impactType>Economic</gtr:impactType></gtr:impactTypes><gtr:outcomeId>56bdb0b06cd705.61210425</gtr:outcomeId><gtr:sector>Healthcare</gtr:sector></gtr:impactSummaryOutput></gtr:impactSummaryOutputs><gtr:intellectualPropertyOutputs/><gtr:keyFindingsOutput><gtr:description>SANS measurements at ISIS Oxford, UK were carried out by a PDRA of Chris Roberts from Delaware, US. SAXS measurements were carried out at NIST, US, by a UCL PDRA. These measurements have revealed structural changes in antibodies as they adhere to chromatographic resin surfaces.</gtr:description><gtr:exploitationPathways>This work will lead to publications and also to a new grant application to extend the work in more detail.</gtr:exploitationPathways><gtr:id>73BE9420-F4AD-49B1-963D-642813A33A92</gtr:id><gtr:outcomeId>56bdaff4a8baa3.42555095</gtr:outcomeId><gtr:sectors><gtr:sector>Healthcare</gtr:sector></gtr:sectors></gtr:keyFindingsOutput><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>2B01FF9C-0700-44B1-B433-E42F26140109</gtr:id><gtr:title>Protein A chromatography increases monoclonal antibody aggregation rate during subsequent low pH virus inactivation hold.</gtr:title><gtr:parentPublicationTitle>Journal of chromatography. A</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/289e5d4a60d6a7b1f05a772a20379552"><gtr:id>289e5d4a60d6a7b1f05a772a20379552</gtr:id><gtr:otherNames>Mazzer AR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0021-9673</gtr:issn><gtr:outcomeId>563fbdd635ba16.66687875</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C90B3476-1ED8-468C-ABFA-3F31C1418560</gtr:id><gtr:title>Neutron reflectivity measurement of protein A-antibody complex at the solid-liquid interface.</gtr:title><gtr:parentPublicationTitle>Journal of chromatography. A</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/289e5d4a60d6a7b1f05a772a20379552"><gtr:id>289e5d4a60d6a7b1f05a772a20379552</gtr:id><gtr:otherNames>Mazzer AR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0021-9673</gtr:issn><gtr:outcomeId>5a734e6ab8be47.08097014</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>196B1670-45DC-458C-9236-2C2436E55E8E</gtr:id><gtr:title>The solution structures of two human IgG1 antibodies show conformational stability and accommodate their C1q and Fc&amp;Icirc;&amp;sup3;R ligands.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/478fecd02f43a7355c5ce5d8c79e3940"><gtr:id>478fecd02f43a7355c5ce5d8c79e3940</gtr:id><gtr:otherNames>Rayner LE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn><gtr:outcomeId>5644b20dc26235.36867141</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">BB/K021354/1</gtr:identifier></gtr:identifiers><gtr:healthCategories/><gtr:researchActivities/><gtr:researchSubjects/><gtr:researchTopics><gtr:researchTopic><gtr:id>D05BC2E0-0345-4A3F-8C3F-775BC42A0819</gtr:id><gtr:text>Unclassified</gtr:text></gtr:researchTopic></gtr:researchTopics><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>